Medsurge Penetrates New EU Market; Spain Orders 2400 Ligator Systems

MEDSURGE is pleased to announce that a new distribution agreement has been established with Arganon - Suministros Hospitalaros S.A. (ASH) of Spain. An initial purchase order of 2,400 ligators was delivered to ASH in late August.

MEDSURGE MEDICAL PRODUCTS CORP.
#210 -- 828 Harbourside Drive
North Vancouver, BC
V7P 3R9
Tel: 604-904-9577;   Fax: 604-904-9588

NEWS RELEASE

September 5, 2003                  Trading Symbol: MSR: TSX-V

Medsurge Penetrates New EU Market; Spain Orders 2400 Ligator Systems

NORTH VANCOUVER, BC, -- MEDSURGE MEDICAL PRODUCTS CORP. (the Company" or Medsurge") is pleased to announce that a new distribution agreement has been established with Arganon - Suministros Hospitalaros S.A. (ASH) of Spain. An initial purchase order of 2,400 ligators was delivered to ASH in late August. Founded in the 1970s, ASH is an established and widely respected national distributor of niche surgical products with sales representatives in all nine regions of Spain. AHS has recently been appointed as exclusive distributor for USSC (Autosuture) now under the umbrella of Tyco Healthcare.

After an extensive evaluation process AHS Director Stephen Whitehouse said We feel that the ORegan hemorrhoid banding system fits perfectly into our product range as an innovative, minimally invasive and cost effective way of treating hemorrhoids. In our initial trials we have received an enthusiastic response from the surgeons approached."

With a population of over 40 million, Spain records approximately 500,000 related procedures per year and represents significant market potential for Medsurges proprietary ligator product.

About Medsurge: Medsurge is a medical device technology company that has developed and is marketing internationally the first single use, patented, disposable, hemorrhoid banding system. The ORegan Hemorrhoid Banding System incorporates 14 counts of new technology in its patents and has numerous regulatory approvals to market including USFDA, European CE, and Japan FDA. Rubber Band Ligation is one of the most common surgical procedures today with an estimated 50,000,000 procedures annually. Medsurge also imports for sale on an exclusive and non-exclusive basis certain niche, proprietary, medical products for the Canadian Market.

For further information, visit the Companys website at www.medsurgemedical.com or the SEDAR website at www.sedar.com or email us at mmorin@medsurgemedical.com.

WARNING: The Company relies upon litigation protection for "forward-looking" statements.

BY THE ORDER OF THE BOARD OF DIRECTORS

Marc Morin"
President and Chief Executive Officer

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.